Health Care

House Democrats are committed to expanding access to quality, affordable health care coverage, strengthening protections for people with pre-existing conditions, and lowering prescription drug prices and the cost of health care overall.

House Democrats are committed to expanding access to quality, affordable health care coverage, strengthening protections for people with pre-existing conditions, and lowering prescription drug prices and the cost of health care overall.
 
Under President Biden and Congressional Democrats, the uninsured rate is at an all-time low. While Republicans vote against legislation to lower health care costs, House Democrats are working to bring down the overall costs of health care and increase access to health care coverage.
 
With the landmark Inflation Reduction Act, House Democrats took direct action to reduce health care costs for millions of Americans. For the first time, Medicare will be able to negotiate prescription drug prices for high-cost drugs. The law also caps out-of-pocket prescription drug costs for Medicare recipients at $2,000 annually and establishes a $35 cap for a month’s supply of insulin. The Inflation Reduction Act also protects progress made under President Biden to expand access to quality, affordable health care coverage by continuing the expanded premium tax credits originally passed in the American Rescue Plan, which lowered health care premiums for millions of working families.
 
This built upon the Affordable Care Act – enacted by President Obama and Congressional Democrats in 2010 – that has put American families in control of their own health care and ended a system that put profits ahead of patients. Since its enactment, 35 million Americans have gained access to quality, affordable health coverage. Americans with pre-existing conditions can no longer be discriminated against by insurance companies. Parents can now keep their children on their insurance plans up to age twenty-six. Insurance companies are no longer allowed to put annual or lifetime limits on coverage or drop people when they get sick. Additionally, thanks to the law, Medicare costs – from premiums and deductibles to overall program spending – have slowed to well below the levels projected before the law passed.
 
These reforms were crucial, especially when the COVID-19 pandemic struck but more action was needed.  That’s why House Democrats worked to enact legislation right away - without any Republican support - to ensure that testing, treatment, and vaccinations for COVID-19 would be covered with no out-of-pocket costs to Americans.

House Democrats remain committed to the goal of affordable, accessible health care for all.  

Related
Hoyer to President Trump: Stop Sabotaging Health Care Access for Millions of Americans
Tonight, President Trump will address the state of our union, and Democrats will be highlighting the dismal state of his record on health care. Joining many of us as our guests tonight are Americans whose lives and health have been affected negatively by this President’s policies and heroes working in our communities to help those needing access to better care.
 
Hoyer, Pelosi Announce Vote on Trump Administration's Medicaid Block Grant Plan Next Week
On Thursday, the House will consider a resolution to disapprove of President Trump’s proposed cuts to Medicaid services through his new illegal block-grant scheme.
Hoyer Statement on the Trump Administration's Medicaid Block Grant Plan
As a candidate, President Trump promised the American people that he would not seek cuts to Medicare, Medicaid, and Social Security.  With today’s announcement, he’s broken that promise yet again.  Fundamentally changing Medicaid by allowing states to take away health coverage and cut health benefits will force low-income Americans, seniors, rural communities, those with disabilities, low income pregnant women facing staggering maternal mortality rates, and Americans seeking treatment for opioid addiction to pay the price. 
 
Hoyer Statement on the 5th Circuit Ruling in the Texas V. U.S. Case on the Affordable Care Act
I am disappointed by today’s decision by a federal appeals court to invalidate a key component of the Affordable Care Act and send the case back to a lower court.  This will only cause further uncertainty for patients, consumers, and providers.  This case was brought by Republicans and supported by the Trump Administration, and it seeks to invalidate the law in its entirety – even the most popular provisions, such as protecting Americans with pre-existing conditions and eliminating annual and lifetime limits on coverage.
Hoyer, Pelosi, Pallone, Neal and Scott Joint Statement Announcing Floor Vote on H.R. 3
Next week, the House of Representatives will pass the Elijah E. Cummings Lower Drug Costs Now Act.
Hoyer Statement on the Ways and Means Committee Markup of H.R.3, the Lower Drug Costs Now Act
Today, the House Committee on Ways and Means completed its markup of H.R. 3, House Democrats’ legislation to lower prescription drug prices. 
Hoyer Statement on House Committees Advancing H.R. 3, the Lower Drug Costs Now Act
Today, House Democrats took a step forward in our effort to lower prescription drug costs for the American people as the Energy and Commerce and the Education and Labor Committees marked up H.R. 3, and the Ways and Means Committee held a hearing on it.
Hoyer Statement on the CBO’s Initial Analysis of the Lower Drug Costs Now Act
Today’s initial estimate from the nonpartisan Congressional Budget Office (CBO) confirms that House Democrats’ bill to lower prescription drug costs, H.R. 3, will produce dramatic savings on prescription drug costs. 
Hoyer Statement on the President's Executive Order on Medicare
President Trump’s announcement today is nothing more than a thinly veiled effort to disguise his Administration’s dismal record on health care and protecting seniors.
Hoyer Statement on the Middle Class Health Benefits Tax Repeal Act
When Democrats enacted the Affordable Care Act (ACA) in 2010, we included an excise tax on high-cost health insurance plans based on economists’ view that it would bend the cost curve downward and achieve savings for consumers by discouraging unnecessary overspending on care.